Freshpet (FRPT) is likely to post in-line Q2, but fiscal 2025 guidance could move lower, UBS said in a Friday note.
The brokerage said it expects Freshpet's net sales growth guidance to move to 13.9% for 2025, compared with the current company outlook of 15% to 18%.
While marketing investments are expected to drive better growth in H2, UBS said it expects management to "walk back" expectations of 14% to 20% net sales growth in H2.
UBS expects the company to lower adjusted earnings before interest, taxes, depreciation, and amortization expectations. The brokerage modelled adjusted EBITDA of $190 million, at the low end of the company's $190 million to $210 million range.
The brokerage said it reiterated its sell rating on the stock and price target of $65 per share.
Price: 70.38, Change: -1.38, Percent Change: -1.92
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.